78
Views
5
CrossRef citations to date
0
Altmetric
Case Report

Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report

, , , &
Pages 2279-2281 | Published online: 01 Sep 2016

References

  • InadaTEvaluation and diagnosis of drug-induced extrapyramidal symptomsYagiGCommentary on the DIEPSS and Guide to Its UsageToykoSeiwa Publishers19961160
  • HamiltonMDevelopment of a rating scale for primary depressive illnessBr J Soc Clin Psychol1967642782966080235
  • de RondeMWKingmaHJMuntsAGSevere Parkinsonism due to metoclopramide: the importance of early recognitionNed Tijdschr Geneeskd201315726A6037 Dutch23835236
  • OyewoleAOAdelufosiAOAbayomiOAcute dystonic reaction as medical emergency: a report of two casesAnn Med Health Sci Res20133345345524116333
  • MoosDDHansenDJMetoclopramide and extrapyramidal symptoms: a case reportJ Perianesth Nurs200823529229918926476
  • NicholsonSDExtra pyramidal side effects associated with paroxetineWest Engl Med J1992107390911308691
  • LeoRJMovement disorders associated with the serotonin selective reuptake inhibitorsJ Clin Psychiatry199657104494548909330
  • SchillevoortIvan PuijenbroekEPde BoerARoosRAJansenPALeufkensHGExtrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reportsInt Clin Psychopharmacol2002172757911892721
  • DestaZWUGMMorochoAMFlockhartDAThe gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6Drug Metab Dispos200230333634311854155